Biohaven Ltd. (BHVN)
(Delayed Data from NYSE)
$15.24 USD
+0.53 (3.60%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $15.25 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Biohaven Ltd. has a market cap of $1.50B, which represents its share price of $14.71 multiplied by its outstanding shares number of 102.11M. As a small-cap company, BHVN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BHVN 15.24 +0.53(3.60%)
Will BHVN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BHVN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BHVN
Company News for Mar 4, 2025
Company News for Jan 2, 2025
BHVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal
Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
BHVN Stock Up as Rare Neurological Disease Study Meets Primary Goal
Other News for BHVN
Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary
Janus Henderson Global Life Sciences Fund Q2 2025 Commentary
Biotech stocks rise following Prasad exit from FDA
12 Health Care Stocks Moving In Wednesday's Intraday Session
Biohaven (BHVN) Shares Surge After FDA Regulatory Shift